A Phase I/II Study of MK-3475 (SCH900475) in Combination with Chemotherapy or Immunotherapy in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I/II Study of MK-3475 (SCH900475) in Combination with Chemotherapy or Immunotherapy in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma

Type of Cancer
Lung
Locations
Hackensack
Sponsor
Merck
Protocol Number
MK-3475-021
Cancer Diagnosis
To Learn More Call
201-510-0910